{'fraction_non_alphanumeric': 0.028362305580969808, 'fraction_numerical': 0.010978956999085087, 'mean_word_length': 5.287356321839081, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Controllable drug release of pH-sensitive liposomes encapsulating artificial cytosol system

The fabrication of cell model containing artificial cytosol is challenging. Herein we constructed an artificial cytosol contained cell model by electroformation method. Agarose was selected as the main component of the artificial cytosol. Sucrose was added into agarose to regulate the sol viscosity and phase transition temperature (Tm). The viscosity of the sol with the mass ratio (agarose-sucrose) 1:9 was closest to the natural cytosolic. DSPC/20 mol% Chol was used to form large unilamellar vesicle (LUV) as cell model compartment. The rhodamine release experiment confirmed that the release of rhodamine from LUVs containing artificial cytosol took more time than that from LUVs containing pure water. The unique release profile makes agarose-sucrose@LUVs suitable as a drug carrier. Doxorubicin (DOX) is loaded in the agarose-sucrose@LUVs, and their half maximum inhibition concentration on HeLa cells is 0.015 μmol L−1, which means 31.7 times increase in inhibition efficiency over free DOX.